[Updated June 16, 2017] A vaccine that researchers say has been over 90 per cent effective against PEDv in clinical trials is on track for another field test in southeast Manitoba. Dr. Volker Gerdts, associate director of research at VIDO-InterVac and one of the lead researchers on the project, says the Canadian Food Inspection Agency